Bolus calculator settings in well-controlled type 1 diabetes patients (glycated hemoglobin < 7%) treated with insulin pumps.

نویسندگان

  • Bartłomiej Matejko
  • Małgorzata Grzanka
  • Beata Kieć-Wilk
  • Maciej T Małecki
  • Tomasz Klupa
چکیده

Corresponding Author: Tomasz Klupa, M.D., Ph.D., Department of Metabolic Diseases, Jagiellonian University, 15 Kopernika St., 31-501 Kraków, Poland; email address [email protected] Two regimens of insulin therapy are used to achieve the goal of near normoglycemia: multiple daily injections (MDI) and continuous subcutaneous insulin infusion (CSII).1 Due to the apparent improvement in quality of life and metabolic control and the greater personal independence (compared with MDI), CSII is becoming an increasingly popular method of insulin delivery for people with type 1 diabetes mellitus (T1DM).1–3 However, one of the major problems related to the use of CSII, or intensive insulin regimens in general, is the accurate calculation of insulin boluses. These calculations should take into account multiple factors, such as current and target blood glucose levels, carbohydrate intake, insulin-to-carbohydrate ratio (ICR), and insulin sensitivity.3 Using the ICR to calculate meal bolus and insulin sensitivity factor (ISF) to correct hyperglycemia are accepted methods of optimization of metabolic control.3–5 These rules are also used to program the bolus calculator (BC), which is an insulin pump function.3–6 The BC uses preprogrammed settings to generate a recommendation of bolus dose.3 There is an agreement that these settings should be individualized for each person; however, some general rules as starting points do exist.4–6 The aim of this analysis was to evaluate BC settings used by CSII-treated T1DM patients, exclusively with good metabolic control [glycated hemoglobin (HbA1c) < 7.0%].

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

BACKGROUND Recently developed technologies for the treatment of type 1 diabetes mellitus include a variety of pumps and pumps with glucose sensors. METHODS In this 1-year, multicenter, randomized, controlled trial, we compared the efficacy of sensor-augmented pump therapy (pump therapy) with that of a regimen of multiple daily insulin injections (injection therapy) in 485 patients (329 adults...

متن کامل

Economic evaluation of continuous subcutaneous insulin infusion for children with diabetes - a pilot study: CSII application for children – economic evaluation

BACKGROUND The objective of this study is to assess the cost of using continuous subcutaneous insulin infusion to treat children with type-1diabetes in Bulgaria, considering changes in body mass index (BMI) and the glycated hemoglobin. The study was performed from the perspective of the Bulgarian National Health Insurance Fund (NHIF) and patients. METHODS A total of 34 pediatric type-1-diabet...

متن کامل

Efficacy and safety of premixed insulin analogs in Asian patients with type 2 diabetes: A systematic review

AIMS/INTRODUCTION The primary aim of this systematic review was to provide an overview of the efficacy and safety of premixed insulin analogs in Asians, specifically East Asians, with type 2 diabetes. MATERIAL AND METHODS The MEDLINE, Embase, Cochrane Library and ClinicalTrials.gov databases were searched from 1 January 1995 to 26 November 2015. Randomized controlled trials involving East Asi...

متن کامل

Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis

INTRODUCTION Combination therapy with insulin and glucagon-like peptide-1 receptor agonists (GLP-1RAs) has already been proven an efficient treatment option for type 2 diabetes. This combination can effectively improve glycated hemoglobin levels, cause weight loss and reduce the dosage of insulin. In addition, it can also reduce the risk of hypoglycemia. Several randomized controlled trials hav...

متن کامل

Hearing Status in Patients with Type 2 Diabetes Mellitus According to Blood-Sugar Control: A Comparative Study

Introduction: It seems that diabetes mellitus (DM) can affect the auditory system due to neuropathy, micro-vascular complications, and hearing cell damage during hyperglycemic states. In the current study, we aimed to compare hearing status in patients with type 2 DM (T2DM) according to their blood-sugar control status.   Materials and Methods: This cross-sectional study was carried out in 104 ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Journal of diabetes science and technology

دوره 7 3  شماره 

صفحات  -

تاریخ انتشار 2013